| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crinetics Pharmaceuticals, Inc. (CRNX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CRNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 426.8K | $16.43M | - | |
| Dir | 116.1K | $4.47M | - | |
| Other | 71.8K | $2.77M | - | |
| Other | 55.0K | $2.12M | - | |
| COO | 55.0K | $2.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2024 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 1,035 | $51.50 | $53,302.50 | -1.5% | +12.3% | -30.6% | |
| Aug 26, 2024 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,000 | $53.19 | $159,570.00 | -4.1% | +5.6% | -41.8% | |
| Aug 12, 2024 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,000 | $47.68 | $143,040.00 | -4.0% | +21.1% | -42.5% | |
| Jul 25, 2024 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,000 | $53.43 | $160,290.00 | -3.8% | +9.5% | -41.9% | |
| Jul 25, 2024 | Wilson Marc53 | CFO | Sale+OE | 19,056 | $53.88 | $1,026,737.28 | -14.6% | +9.5% | -41.9% | |
| Jul 15, 2024 | Wilson Marc53 | CFO | Sale+OE | 25,000 | $55.00 | $1,375,000.00 | -18.4% | -1.9% | -41.2% | |
| Jul 15, 2024 | Knight Jeff E.68 | Chief Operating Officer | Sale+OE | 27,000 | $55.00 | $1,485,000.00 | -34.3% | -1.9% | -41.2% | |
| Jul 10, 2024 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,000 | $48.55 | $145,650.00 | -3.7% | +1.8% | -37.0% | |
| Jul 5, 2024 | Hassard James61 | Chief Commercial Officer | Sale+OE | 15,000 | $44.08 | $661,200.00 | -33.9% | +20.4% | -33.7% | |
| Jul 3, 2024 | Pizzuti Dana56 | Chief Med And Dev Officer | Sale+OE | 14,375 | $44.87 | $645,006.25 | -33.5% | +17.5% | -32.6% |